PHARVAT

PHARVAT is a European Commission (EC) Seventh Framework Programme (FP7) funded project aiming to generate a harmonised procedure to permit pre-clinical selection of vaccine adjuvants. The project is running for a two year period and was initiated in November 2009 with an overall budget of € 300 000.

News

17 June 2016

EVI moves to new address

As of 15 June 2016 EVI is domiciled at:

European Vaccine Initiative
UniversitätsKlinikum Heidelberg
Vossstrasse 2, Geb. 4040
69115 Heidelberg, Germany

14 June 2016

VAC2VAC, a new project funded by the Innovative Medicines Initiative (IMI2)

European public and private organisations are collaborating in VAC2VAC, a new project funded by the Innovative Medicines Initiative (IMI2) to develop and validate quality testing approaches for both human and veterinary vaccines using non-animal methods.

27 January 2016

EVI is currently offering three exciting positions

Three new positions offering exciting challenges to qualified applicants are now available at EVI: 

Senior Project Manager, deadline 15 March 2016
Project Manager, deadline 15 March 2016
Programme Manager Assistant, deadline 15 March 2016